Price history, fund statistics and profile — an exchange-traded fund.
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund managed by ARK ETF Trust in the "Health" category. It manages roughly $2 billion in assets.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies").
Interactive chart & fund stats →
| Expense ratio | 0.75% |
| Trailing yield | 0.00% |
| Assets under management | $2 billion |
| Fund category | Health |
| Fund family | ARK ETF Trust |
| Inception | 2014-10-31 |
The live price chart, fund profile and news are in the interactive ARKG viewer.
About TickerBase · Data methodology & sources · Privacy · Terms